Management Committee
Prof. Michal Lotem
The Founder and Head of the Hadassah Cancer Research Institute, Professor Michal Lotem is an international expert in skin cancer and clinical oncology, driving cutting-edge scientific innovation at the HCRI since its inception in 2019. Her vision for HCRI is to investigate the nature of various cancers and enable HRCI’s physicians, scientists and researchers to develop new and personalized ways to manipulate the immune system to cure cancer, with the goal of eradicating cancer.
Prof. Rotem Karni
Hebrew University-Hadassah Medical School, Jerusalem, IL, and University of Pennsylvania, USA
Amalia Herszkowicz
Amalia is an experienced executive specializing in leading scientific breakthroughs through “first-in-human” clinical trials. As COO of the Hadassah Cancer Research Institute, she leverages her C-Level experience and entrepreneurial skills. Previously, she led companies developing COVID-19 treatments and pan-cancer screening tests. She has a 20-year track record of translating innovation into marketable solutions across diagnostics, therapeutics, and medical devices.
